TLSI
TriSalus Life Sciences develops therapies for liver and pancreatic tumors by combining innovative delivery technologies with standard-of-care therapies and investigational immunotherapy. The company focuses on oncology, aiming to transform outcomes for patients with solid tumors through proprietary drug-delivery approaches and immuno-oncology programs. Headquartered in the United States, TriSalus communicates a global research and development focus across clinical trials and scientific publications.
No recent news for this company.
No recent deals for this company.